Harpaz R - Search Results

1

Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.

Boyce RD, Ryan PB, Norén GN, Schuemie MJ, Reich C, Duke J, Tatonetti NP, Trifirò G, Harpaz R, Overhage JM, Hartzema AG, Khayter M, Voss EA, Lambert CG, Huser V, Dumontier M. Boyce RD, et al. Among authors: harpaz r. Drug Saf. 2014 Aug;37(8):557-67. doi: 10.1007/s40264-014-0189-0. Drug Saf. 2014. PMID: 24985530 Free PMC article.

2

Novel data-mining methodologies for adverse drug event discovery and analysis.

Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Harpaz R, et al. Clin Pharmacol Ther. 2012 Jun;91(6):1010-21. doi: 10.1038/clpt.2012.50. Clin Pharmacol Ther. 2012. PMID: 22549283 Free PMC article. Review.

3

Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system.

Harpaz R, DuMouchel W, LePendu P, Bauer-Mehren A, Ryan P, Shah NH. Harpaz R, et al. Clin Pharmacol Ther. 2013 Jun;93(6):539-46. doi: 10.1038/clpt.2013.24. Epub 2013 Feb 11. Clin Pharmacol Ther. 2013. PMID: 23571771 Free PMC article.

4

Text mining for adverse drug events: the promise, challenges, and state of the art.

Harpaz R, Callahan A, Tamang S, Low Y, Odgers D, Finlayson S, Jung K, LePendu P, Shah NH. Harpaz R, et al. Drug Saf. 2014 Oct;37(10):777-90. doi: 10.1007/s40264-014-0218-z. Drug Saf. 2014. PMID: 25151493 Free PMC article.

5

Toward multimodal signal detection of adverse drug reactions.

Harpaz R, DuMouchel W, Schuemie M, Bodenreider O, Friedman C, Horvitz E, Ripple A, Sorbello A, White RW, Winnenburg R, Shah NH. Harpaz R, et al. J Biomed Inform. 2017 Dec;76:41-49. doi: 10.1016/j.jbi.2017.10.013. Epub 2017 Nov 1. J Biomed Inform. 2017. PMID: 29081385 Free PMC article.

6

Response to "Logistic regression in signal detection: another piece added to the puzzle".

Harpaz R, DuMouchel W, LePendu P, Bauer-Mehren A, Ryan P, Shah NH. Harpaz R, et al. Clin Pharmacol Ther. 2013 Sep;94(3):313. doi: 10.1038/clpt.2013.125. Epub 2013 Jun 12. Clin Pharmacol Ther. 2013. PMID: 23756371 No abstract available.

7

Biclustering of adverse drug events in the FDA's spontaneous reporting system.

Harpaz R, Perez H, Chase HS, Rabadan R, Hripcsak G, Friedman C. Harpaz R, et al. Clin Pharmacol Ther. 2011 Feb;89(2):243-50. doi: 10.1038/clpt.2010.285. Epub 2010 Dec 29. Clin Pharmacol Ther. 2011. PMID: 21191383 Free PMC article.

8

Pharmacovigilance using clinical notes.

LePendu P, Iyer SV, Bauer-Mehren A, Harpaz R, Mortensen JM, Podchiyska T, Ferris TA, Shah NH. LePendu P, et al. Among authors: harpaz r. Clin Pharmacol Ther. 2013 Jun;93(6):547-55. doi: 10.1038/clpt.2013.47. Epub 2013 Mar 4. Clin Pharmacol Ther. 2013. PMID: 23571773 Free PMC article.

9

Toward enhanced pharmacovigilance using patient-generated data on the internet.

White RW, Harpaz R, Shah NH, DuMouchel W, Horvitz E. White RW, et al. Among authors: harpaz r. Clin Pharmacol Ther. 2014 Aug;96(2):239-46. doi: 10.1038/clpt.2014.77. Epub 2014 Apr 8. Clin Pharmacol Ther. 2014. PMID: 24713590 Free PMC article.

10

Big Data and Adverse Drug Reaction Detection.

Harpaz R, DuMochel W, Shah NH. Harpaz R, et al. Clin Pharmacol Ther. 2016 Mar;99(3):268-70. doi: 10.1002/cpt.302. Epub 2015 Dec 23. Clin Pharmacol Ther. 2016. PMID: 26575203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters